Htg Molecular Diagnostics Inc (HTGM)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Barat Officer	$0.80	888	$710.40	421	2023-06-08	Filing
Johnson Officer, Director	$0.72	5,718	$4,109.53	256,121	2019-12-26	Filing
Mcmeans Officer	$2.11	945	$1,992.15	42,303	2017-12-01	Filing
Mcmeans Officer	$2.26	945	$2,135.70	43,248	2017-11-01	Filing
Mcmeans Officer	$2.27	946	$2,148.27	44,193	2017-10-16	Filing
Novo Large Shareholder	$1.75	720,214	$1,260,590.56	0	2017-08-25	Filing
Novo Large Shareholder	$1.91	382,437	$729,919.26	720,214	2017-08-24	Filing
Novo Large Shareholder	$2.02	47,162	$95,474.75	1,102,651	2017-08-23	Filing
Novo Large Shareholder	$2.01	12,641	$25,412.20	1,199,599	2017-08-22	Filing
Novo Large Shareholder	$2.02	12,845	$25,976.44	1,212,240	2017-08-21	Filing
Novo Large Shareholder	$2.10	55,100	$115,599.80	1,225,085	2017-08-18	Filing
Glaxosmithkline Other	$10.15	300,000	$3,045,180.00	792,781	2017-03-27	Filing
Glaxosmithkline Other	$10.15	300,000	$3,045,180.00	792,781	2017-03-27	Filing
Lubniewski Officer	$2.92	87	$254.35	25,027	2016-04-04	Filing
Lubniewski Officer	$2.89	709	$2,048.16	25,114	2016-04-01	Filing
Mcmeans Officer	$2.92	175	$511.63	19,976	2016-04-04	Filing
Mcmeans Officer	$2.89	1,426	$4,119.43	20,151	2016-04-01	Filing
Johnson Officer, Director	$2.92	538	$1,572.90	50,771	2016-04-04	Filing
Johnson Officer, Director	$2.89	4,376	$12,641.39	51,309	2016-04-01	Filing
Gordon Officer	$2.92	183	$535.02	17,522	2016-04-04	Filing